TY - JOUR AU - Levi, M. AU - Jonge, E. AU - Poll, T. PY - 2003 DA - 2003// TI - Sepsis and disseminated intravascular coagulation JO - J Thromb Thrombolysis VL - 16 UR - https://doi.org/10.1023/B:THRO.0000014592.27892.11 DO - 10.1023/B:THRO.0000014592.27892.11 ID - Levi2003 ER - TY - JOUR AU - Ogura, H. AU - Gando, S. AU - Saitoh, D. AU - Takeyama, N. AU - Kushimoto, S. AU - Fujishima, S. PY - 2014 DA - 2014// TI - Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study JO - J Infect Chemother VL - 20 UR - https://doi.org/10.1016/j.jiac.2013.07.006 DO - 10.1016/j.jiac.2013.07.006 ID - Ogura2014 ER - TY - JOUR AU - Rhodes, A. AU - Evans, L. E. AU - Alhazzani, W. AU - Levy, M. M. AU - Antonelli, M. AU - Ferrer, R. PY - 2017 DA - 2017// TI - Surviving sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016 JO - Intensive Care Med VL - 43 UR - https://doi.org/10.1007/s00134-017-4683-6 DO - 10.1007/s00134-017-4683-6 ID - Rhodes2017 ER - TY - JOUR AU - Nishida, O. AU - Ogura, H. AU - Egi, M. AU - Fujishima, S. AU - Hayashi, Y. AU - Iba, T. PY - 2018 DA - 2018// TI - The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016) JO - J Intensive Care VL - 6 UR - https://doi.org/10.1186/s40560-017-0270-8 DO - 10.1186/s40560-017-0270-8 ID - Nishida2018 ER - TY - JOUR AU - Kienast, J. AU - Juers, M. AU - Wiedermann, C. J. AU - Hoffmann, J. N. AU - Ostermann, H. AU - Strauss, R. PY - 2006 DA - 2006// TI - Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation JO - J Thromb Haemost VL - 4 UR - https://doi.org/10.1111/j.1538-7836.2005.01697.x DO - 10.1111/j.1538-7836.2005.01697.x ID - Kienast2006 ER - TY - JOUR AU - Warren, B. L. AU - Eid, A. AU - Singer, P. AU - Pillay, S. S. AU - Carl, P. AU - Novak, I. PY - 2001 DA - 2001// TI - Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial JO - JAMA VL - 286 UR - https://doi.org/10.1001/jama.286.15.1869 DO - 10.1001/jama.286.15.1869 ID - Warren2001 ER - TY - JOUR AU - Allingstrup, M. AU - Wetterslev, J. AU - Ravn, F. B. AU - Møller, A. M. AU - Afshari, A. PY - 2016 DA - 2016// TI - Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis JO - Intensive Care Med VL - 42 UR - https://doi.org/10.1007/s00134-016-4225-7 DO - 10.1007/s00134-016-4225-7 ID - Allingstrup2016 ER - TY - JOUR AU - Wiedermann, C. J. PY - 2018 DA - 2018// TI - Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited JO - J Thromb Haemost VL - 16 UR - https://doi.org/10.1111/jth.13950 DO - 10.1111/jth.13950 ID - Wiedermann2018 ER - TY - JOUR AU - Vincent, J. L. AU - Ramesh, M. K. AU - Ernest, D. AU - LaRosa, S. P. AU - Pachl, J. AU - Aikawa, N. AU - Kaul, I. PY - 2013 DA - 2013// TI - A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation JO - Crit Care Med VL - 41 UR - https://doi.org/10.1097/CCM.0b013e31828e9b03 DO - 10.1097/CCM.0b013e31828e9b03 ID - Vincent2013 ER - TY - JOUR AU - Vincent, J. e. a. n. -. L. o. u. i. s. AU - Francois, B. r. u. n. o. AU - Zabolotskikh, I. g. o. r. AU - Daga, M. r. a. d. u. l. K. u. m. a. r. AU - Lascarrou, J. e. a. n. -. B. a. p. t. i. s. t. e. AU - Kirov, M. i. k. h. a. i. l. Y. AU - Pettilä, V. i. l. l. e. AU - Wittebole, X. a. v. i. e. r. AU - Meziani, F. e. r. h. a. t. AU - Mercier, E. m. m. a. n. u. e. l. l. e. AU - Lobo, S. u. z. a. n. a. M. AU - Barie, P. h. i. l. i. p. S. AU - Crowther, M. a. r. k. AU - Esmon, C. h. a. r. l. e. s. T. AU - Fareed, J. a. w. e. d. AU - Gando, S. a. t. o. s. h. i. AU - Gorelick, K. e. n. n. e. t. h. J. AU - Levi, M. a. r. c. e. l. AU - Mira, J. e. a. n. -. P. a. u. l. AU - Opal, S. t. e. v. e. n. M. AU - Parrillo, J. o. s. e. p. h. AU - Russell, J. a. m. e. s. A. AU - Saito, H. i. d. e. h. i. k. o. AU - Tsuruta, K. a. z. u. h. i. s. a. AU - Sakai, T. a. k. u. m. i. AU - Fineberg, D. a. v. i. d. PY - 2019 DA - 2019// TI - Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy JO - JAMA VL - 321 UR - https://doi.org/10.1001/jama.2019.5358 DO - 10.1001/jama.2019.5358 ID - Vincent2019 ER - TY - JOUR AU - Yamakawa, K. AU - Murao, S. AU - Aihara, M. PY - 2019 DA - 2019// TI - Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis JO - Thromb Haemost VL - 119 UR - https://doi.org/10.1055/s-0038-1676345 DO - 10.1055/s-0038-1676345 ID - Yamakawa2019 ER - TY - JOUR AU - Umemura, Y. AU - Yamakawa, K. AU - Ogura, H. AU - Yuhara, H. AU - Fujimi, S. PY - 2016 DA - 2016// TI - Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials JO - J Thromb Haemost VL - 14 UR - https://doi.org/10.1111/jth.13230 DO - 10.1111/jth.13230 ID - Umemura2016 ER - TY - JOUR AU - Hayakawa, M. AU - Ono, K. PY - 2018 DA - 2018// TI - A summary of the Japan septic disseminated intravascular coagulation study JO - Acute Med Surg VL - 5 UR - https://doi.org/10.1002/ams2.326 DO - 10.1002/ams2.326 ID - Hayakawa2018 ER - TY - JOUR AU - Engelmann, B. AU - Massberg, S. PY - 2013 DA - 2013// TI - Thrombosis as an intravascular effector of innate immunity JO - Nat Rev Immunol VL - 13 UR - https://doi.org/10.1038/nri3345 DO - 10.1038/nri3345 ID - Engelmann2013 ER - TY - JOUR AU - Gaertner, F. AU - Massberg, S. PY - 2016 DA - 2016// TI - Blood coagulation in immunothrombosis—at the frontline of intravascular immunity JO - Semin Immunol VL - 28 UR - https://doi.org/10.1016/j.smim.2016.10.010 DO - 10.1016/j.smim.2016.10.010 ID - Gaertner2016 ER - TY - JOUR AU - Iba, T. AU - Levy, J. H. AU - Hirota, T. AU - Hiki, M. AU - Sato, K. AU - Murakami, T. AU - Nagaoka, I. PY - 2018 DA - 2018// TI - Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis JO - Thromb Res VL - 171 UR - https://doi.org/10.1016/j.thromres.2018.09.042 DO - 10.1016/j.thromres.2018.09.042 ID - Iba2018 ER - TY - JOUR AU - Iba, T. AU - Thachil, J. PY - 2016 DA - 2016// TI - Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan JO - Int J Hematol VL - 103 UR - https://doi.org/10.1007/s12185-015-1904-z DO - 10.1007/s12185-015-1904-z ID - Iba2016 ER - TY - JOUR AU - Iba, T. AU - Levy, J. H. AU - Raj, A. AU - Warkentin, T. E. PY - 2019 DA - 2019// TI - Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation JO - J Clin Med VL - 8 UR - https://doi.org/10.3390/jcm8050728 DO - 10.3390/jcm8050728 ID - Iba2019 ER - TY - JOUR AU - Umemura, Y. AU - Yamakawa, K. PY - 2018 DA - 2018// TI - Optimal patient selection for anticoagulant therapy in sepsis: an evidence-based proposal from Japan JO - J Thromb Haemost VL - 16 UR - https://doi.org/10.1111/jth.13946 DO - 10.1111/jth.13946 ID - Umemura2018 ER -